Showing results (3161-3170 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|September 28, 2007
Atypical cytostatic mechanism of N-1-sulfonylcytosine derivatives determined by in vitro screening and computational analysisFran Supek, Marijeta Kralj, Marko Marjanović, et al.
Investigational New Drugs|August 16, 2008
Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell linesXishan Xiong, Yangliang Ye, Lili Fu, et al.
Investigational New Drugs|August 16, 2008
Antioxidant and anticancer efficacy of hesperidin in benzo(a)pyrene induced lung carcinogenesis in miceSattu Kamaraj, Gopalakrishnan Ramakrishnan, Pandi Anandakumar, et al.
Investigational New Drugs|August 13, 2008
Enhancement of the action of the antivascular drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA; ASA404) by non-steroidal anti-inflammatory drugsL-C Steve Wang, Lai-Ming Ching, James W Paxton, et al.
Investigational New Drugs|July 24, 2008
Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesisSelvaraj Aranganathan, Jayabal Panneer Selvam, Namasivayam Nalini
Investigational New Drugs|November 18, 2008
Mixed steroidal tetraoxanes induce apoptotic cell death in tumor cellsZeljko Zizak, Zorica Juranić, Dejan Opsenica, et al.
Investigational New Drugs|November 13, 2008
Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancerMichael Michael, Peter Gibbs, Robert Smith, et al.
Investigational New Drugs|September 14, 2007
Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activityPraveen Rajendran, Manu Jaggi, Manoj K Singh, et al.
Investigational New Drugs|October 29, 2008
Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumorsAxel-R Hanauske, Herlinde Dumez, Martine Piccart, et al.
Investigational New Drugs|October 29, 2008
Artemisinin reduces human melanoma cell migration by down-regulating alpha V beta 3 integrin and reducing metalloproteinase 2 productionElisabetta Buommino, Adone Baroni, Nunzia Canozo, et al.
Pageof 372